Fig. 3.
Pathological assessment for each regional pathology derived from histology as per the protocol discussed in Section 2.3. The columns are severity ratings (left to right): 0-3. The shown pathologies are: amyloid- plaques (NAB228 antibody), p-tau pathology (PHF-1 antibody), α-synuclein (Syn303 antibody), TDP-43 inclusions (pS409/410 antibody), and neuron loss (Hematoxylin and Eosin staining) in different cortical and medial temporal lobe regions included in the current work.